Send patients the intake packet and pre visit checklist, then log each intake as soon as its received
In a phase II study, MariTide demonstrated weight loss of up to approximately 20% in people living with obesity without T2DM, compared with 2.6% in the placebo group and up to approximately 17% in those who have obesity and T2DM 10
contributed to conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, validation, and writing-review and editing and was responsible for funding acquisition
Most medically supervised patients lose 12 pounds per week on tirzepatide, meaning 50 pounds of weight loss typically takes 6 to 12 months depending on dose, metabolism, and adherence